Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Kidney International

• Publication date

  2005-12-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/J.1523-1755.2005.00742.XPMID 16316346
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure

  2004cited by this paper
• Hypoxic induction of Ctgf is directly mediated by Hif-1.

  2004cited by this paper
• Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis.

  2004cited by this paper
• The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.

  2004cited by this paper
• Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.

  2004cited by this paper
• Depletion of Intracellular Ascorbate by the Carcinogenic Metals Nickel and Cobalt Results in the Induction of Hypoxic Stress*

  2004cited by this paper
• Erythropoietin protects against ischaemic acute renal injury.

  2004cited by this paper
• Local actions of endogenous angiotensin II in injured glomeruli.

  2004cited by this paper
• Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells.

  2004cited by this paper
• Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models.

  2004cited by this paper
• Evidence of tubular hypoxia in the early phase in the remnant kidney model.

  2004cited by this paper
• A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.

  2003cited by this paper
• Hypoxia-induced apoptosis in cultured glomerular endothelial cells: involvement of mitochondrial pathways.

  2003cited by this paper
• Angiotensin II Blockade Augments Renal Cortical Microvascular pO2 Indicating a Novel, Potentially Renoprotective Action

  2003cited by this paper
• Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax.

  2003cited by this paper
• Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels.

  2003cited by this paper
• Non-erythroid functions of erythropoietin.

  2003cited by this paper
• Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts.

  2003cited by this paper
• Role of Hypoxia in the Pathogenesis of Renal Disease

  2003cited by this paper
• A novel protective effect of erythropoietin in the infarcted heart.

  2003cited by this paper
• Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats.

  2003cited by this paper
• Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension.

  2003cited by this paper
• Peritubular capillary regression during the progression of experimental obstructive nephropathy.

  2002cited by this paper
• How oxygen makes its presence felt.

  2002cited by this paper
• Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.

  2002cited by this paper
• C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys.

  2002cited by this paper
• Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis.

  2002cited by this paper
• Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression

  2002cited by this paper
• Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.

  2001cited by this paper
• HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing

  2001cited by this paper
• Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation

  2001cited by this paper
• Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.

  2001cited by this paper
• Protective role of nitric oxide in a model of thrombotic microangiopathy in rats.

  2001cited by this paper
• Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis.

  2001cited by this paper
• Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.

  2001cited by this paper
• Heme oxygenase-1 inhibits TNF-α-induced apoptosis in cultured fibroblasts

  2000cited by this paper
• Peritubular capillary injury during the progression of experimental glomerulonephritis in rats.

  2000cited by this paper
• Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells.

  2000cited by this paper
• Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts.

  2000cited by this paper
• Neurons Overexpressing Heme Oxygenase‐1 Resist Oxidative Stress‐Mediated Cell Death

  2000cited by this paper
• Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia.

  2000cited by this paper
• Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.

  2000cited by this paper
• Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis

  2000cited by this paper
• Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model).

  1999cited by this paper
• Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.

  1999cited by this paper
• Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome.

  1999cited by this paper
• Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease.

  1999cited by this paper
• Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade.

  1998cited by this paper
• Progressive renal disease: the chronic hypoxia hypothesis.

  1998cited by this paper
• Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism.

  1997cited by this paper
• Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target?

  1997cited by this paper
• Will angiotensin II receptor antagonists be renoprotective in humans?

  1996cited by this paper
• Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats.

  1984cited by this paper
• Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate.

  1981cited by this paper
• Reversal of renal cortical actions of angiotensin II by verapamil and manganese.

  1979cited by this paper

• Acute Toxicity of Aluminum, Cobalt, and Lithium Chlorides in Albino wistar Mice: Determination of Lethal Doses

  2024cites this paper
• CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation

  2024cites this paper
• Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression

  2024cites this paper
• Hypoxia-Driven Responses in Chronic Kidney Disease

  2023cites this paper
• Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia

  2023cites this paper
• Hypoxia and renal fibrosis.

  2023cites this paper
• Early biomarkers of nephrotoxicity associated with the use of anti-VEGF drugs.

  2022cites this paper
• Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors.

  2022cites this paper
• Therapeutic Implications of Ferroptosis in Renal Fibrosis

  2022cites this paper
• Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention

  2022cites this paper
• Renal hypoxia–HIF–PHD–EPO signaling in transition metal nephrotoxicity: friend or foe?

  2022cites this paper
• Disturbance of Hypoxia Response and Its Implications in Kidney Diseases

  2022cites this paper
• HIF-1α is transcriptionally regulated by NF-κB in acute kidney injury.

  2021cites this paper
• Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantages.

  2021cites this paper
• A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats

  2021cites this paper
• Treatment of Diabetic Kidney Disease: Current and Future

  2021cites this paper
• Hypoxia-Inducible Factor and Oxygen Biology in the Kidney.

  2020cites this paper
• Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease.

  2020cites this paper
• Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats

  2020cites this paper
• Hypoxia in chronic kidney disease: towards a paradigm shift?

  2020cites this paper
• Role of Hypoxia Inducible Factor-1 Alpha in Early Stage Renal Failure and Its Relationship with Biochemical and Inflammatory Parameters

  2019cites this paper
• Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair

  2019cites this paper
• A stimuli-responsive drug release nanoplatform for kidney-specific anti-fibrosis treatment.

  2019cites this paper
• Factors affecting the transition of acute kidney injury to chronic kidney disease: Potential mechanisms and future perspectives.

  2019cites this paper
• Mechanisms of hypoxia signalling: new implications for nephrology

  2019cites this paper
• How Acute Kidney Injury Contributes to Renal Fibrosis.

  2019cites this paper
• Repair Effects of KGF on Ischemia-Reperfusion-Induced Flap Injury via Activating Nrf2 Signaling.

  2019cites this paper
• DNA Damage Repair and DNA Methylation in the Kidney

  2019cites this paper
• Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genes

  2018cites this paper
• The smell of renal protection against chronic kidney disease: Hydrogen sulfide offers a potential stinky remedy

  2018cites this paper
• Transcription Factors as Therapeutic Targets in Chronic Kidney Disease

  2018cites this paper
• Cobalt treatment does not prevent glomerular morphological alterations in type 1 diabetic rats

  2018cites this paper
• Tipping the Balance from Angiogenesis to Fibrosis in Chronic Kidney Disease

  2018cites this paper
• The Tubulointerstitial Pathophysiology of Progressive Kidney Disease.

  2017cites this paper
• Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease

  2017cites this paper
• Signalling pathways involved in hypoxia‐induced renal fibrosis

  2017cites this paper
• Renal Hypoxia in CKD; Pathophysiology and Detecting Methods

  2017cites this paper
• A mechanistic link between renal ischemia and fibrosis

  2017cites this paper
• Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease

  2017cites this paper
• Cobalt Chloride Induces Expression and Function of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Renal Proximal Tubular Epithelial Cell Line HK-2.

  2017cites this paper
• PROTECTIVE EFFECTS OF METFORMIN IN AN IN VITRO MODEL OF PROTEINURIC KIDNEY DISEASE

  2017cites this paper
• Selective tubular activation of hypoxia-inducible factor-2α has dual effects on renal fibrosis

  2017cites this paper
• Expanding roles of the hypoxia-response network in chronic kidney disease

  2016cites this paper
• Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3.

  2016cites this paper
• AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.

  2016cites this paper
• HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond

  2016cites this paper
• New insights into molecular mechanisms of epigenetic regulation in kidney disease

  2016cites this paper
• Hypoxia and hypoxia-inducible factors in chronic kidney disease

  2016cites this paper
• Preconditioned suppression of prolyl-hydroxylases attenuates renal injury but increases mortality in septic murine models.

  2016cites this paper
• [Therapeutic approaches targeting fibrosis and hypoxia in the kidney].

  2015cites this paper
• Effects of autologous SCF- and G-CSF-mobilized bone marrow stem cells on hypoxia-inducible factor-1 in rats with ischemia-reperfusion renal injury.

  2015cites this paper
• Enhanced renoprotective effect of HIF-1α modified human adipose-derived stem cells on cisplatin-induced acute kidney injury in vivo

  2015cites this paper
• Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δ

  2015cites this paper
• Activation of hypoxia-inducible factors prevents diabetic nephropathy.

  2015cites this paper
• The role of hypoxia and Morg1 in renal injury

  2015cites this paper
• Chronic exposure to cobalt compounds — an in vivo study

  2014cites this paper
• Role of hypoxia in progressive chronic kidney disease and implications for therapy

  2014cites this paper
• A novel CRIg‐targeted complement inhibitor protects cells from complement damage

  2014cites this paper
• Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury.

  2014cites this paper
• Silencing of hypoxia-inducible factor-1α gene attenuates chronic ischemic renal injury in two-kidney, one-clip rats.

  2014cites this paper
• Kidney Protection by Hypothermic Total Liquid Ventilation after Cardiac Arrest in Rabbits

  2014cites this paper
• Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials

  2013cites this paper
• Novel therapeutic strategy with hypoxia-inducible factors via reversible epigenetic regulation mechanisms in progressive tubulointerstitial fibrosis.

  2013cites this paper
• Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms

  2013cites this paper
• Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys.

  2013cites this paper
• Oxidative and Endoplasmic Reticulum (ER) Stress in Tissue Fibrosis

  2013cites this paper
• Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys

  2013cites this paper
• Is Hif-1a Expression Important in Proliferative and Nonproliferative Glomerulopathy in Terms of Prognosis?

  2013cites this paper
• Hypoxic Preconditioning with Cobalt of Bone Marrow Mesenchymal Stem Cells Improves Cell Migration and Enhances Therapy for Treatment of Ischemic Acute Kidney Injury

  2013cites this paper
• Angiotensin II blockade and renal protection.

  2013cites this paper
• Regulation of hypoxia‐inducible factor in kidney disease

  2013cites this paper
• Angiogenesis and hypoxia in the kidney

  2013cites this paper
• Transient hypoxia‐inducible factor activation in rat renal ablation and reduced fibrosis with L‐mimosine

  2012cites this paper
• Hypoxia-Inducible Factor Activation Protects the Kidney from Gentamicin-Induced Acute Injury

  2012cites this paper
• Urinary Hypoxia-Inducible Factor-1alpha Levels Are Associated with Histologic Chronicity Changes and Renal Function in Patients with Lupus Nephritis

  2012cites this paper
• Cytoprotection behind heme oxygenase-1 in renal diseases.

  2012cites this paper
• Perspective in Chronic Kidney Disease: Targeting Hypoxia-Inducible Factor (HIF) as Potential Therapeutic Approach

  2012cites this paper
• 腎臓病のfinal common pathway：低酸素障害

  2012cites this paper
• Sublytic C5b-9 Complexes Induce Apoptosis of Glomerular Mesangial Cells in Rats with Thy-1 Nephritis through Role of Interferon Regulatory Factor-1-dependent Caspase 8 Activation*

  2012cites this paper
• AG490 promotes HIF-1α accumulation by inhibiting its hydroxylation.

  2012cites this paper
• Renal Tubular HIF-2α Expression Requires VHL Inactivation and Causes Fibrosis and Cysts

  2012cites this paper
• Selective stabilization of HIF-1α in renal tubular cells by 2-oxoglutarate analogues.

  2012cites this paper
• The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.

  2012cites this paper
• Novel Therapeutic Approaches Against Oxidative Stress and Hypoxia, Targeting Intracellular Sensor Molecules for Oxygen and Oxidative Stress

  2011cites this paper
• Tubular deficiency of von Hippel-Lindau attenuates renal disease progression in anti-GBM glomerulonephritis.

  2011cites this paper
• Silencing of Hypoxia-Inducible Factor-1&agr; Gene Attenuated Angiotensin II–Induced Renal Injury in Sprague-Dawley Rats

  2011cites this paper
• Mitochondrial damage-induced impairment of angiogenesis in the aging rat kidney

  2011cites this paper
• Pathogenesis of tubular interstitial nephritis.

  2011cites this paper
• Spread of glomerular to tubulointerstitial disease with a focus on proteinuria.

  2010cites this paper
• The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease

  2010cites this paper
• Diabetic nephropathy: a disorder of oxygen metabolism?

  2010cites this paper
• The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease

  2010cites this paper
• The sweet side of HIF.

  2010cites this paper
• Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney.

  2010cites this paper
• Factor inhibiting HIF limits the expression of hypoxia-inducible genes in podocytes and distal tubular cells.

  2010cites this paper
• Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD.

  2009cites this paper
• Apoptosis of glomerular mesangial cells induced by sublytic C5b‐9 complexes in rats with Thy‐1 nephritis is dependent on Gadd45γ upregulation

  2009cites this paper
• Novel therapeutic approach targeting the HIF-HRE system in the kidney.

  2009cites this paper
• Metallothionein is upregulated by hypoxia and stabilizes hypoxia-inducible factor in the kidney.

  2009cites this paper
• Review article: How cells sense oxygen: Lessons from and for the kidney

  2009cites this paper